WO2001060330A1 - Tanning preparation for the skin - Google Patents
Tanning preparation for the skin Download PDFInfo
- Publication number
- WO2001060330A1 WO2001060330A1 PCT/NL2001/000122 NL0100122W WO0160330A1 WO 2001060330 A1 WO2001060330 A1 WO 2001060330A1 NL 0100122 W NL0100122 W NL 0100122W WO 0160330 A1 WO0160330 A1 WO 0160330A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tanning
- preparation according
- tanning preparation
- emulsion
- skin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/04—Preparations for care of the skin for chemically tanning the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0295—Liquid crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/604—Alkylpolyglycosides; Derivatives thereof, e.g. esters
Definitions
- the invention relates to a tanning preparation for the skin comprising at least one tyrosine derivative of formula 1
- this known preparation comprises an adenosine compound such as an ester or a salt of adenosine mono-, di- or triphosphoric acid.
- Adenosine di- and triphosphate are known to be involved in various enzymatic reactions in the body, in particular in processes requiring energy such as the oxidation of sugars, proteins and fats .
- the activator used is not a substance which naturally occurs in the body and has an enzymatic reaction, but instead a compound which preferably has humectant activity.
- the invention therefore relates, in a firs embodiment, to a tanning preparation of the type mentioned at the outset, which is characterized in that the activator consists of an aliphatic polyol having at least 10 C atoms in the molecule.
- the aliphatic polyol consists of a hexadecanetriol, in particular phytantriol.
- Phytantriol or 3 , 7, 11, 15-tetramethyl-l , 2 , 3-hexadecane- triol, is a compound which improves the moisture retention capability of the skin and of hair and is therefore used in shampoos and hair conditioners; in this context, the Japanese patent application Kokai No JP-A2-61, 236 , 737 can be mentioned.
- an aliphatic polyol, and in particular phytantriol improves the deposition of a tyrosine derivative as specified hereinabove on and in the skin, thereby allowing rapid and persistent, natural tanning of the skin to be achieved.
- Such an effect is rather surprising, all the more since only very small amounts of aliphatic polyol, in particular phytantriol, need be present in the tanning preparation.
- the tanning preparation according to the invention merely contains at least 0.01 wt% of phytantriol, it being noted in this context that even with this very small amount of phytantriol, rapid tanning of the skin is achieved.
- Tyrosine derivatives which are particularly suitable for use in a tanning preparation according to the invention are N-acetyltyrosine; N-acetyl yrosine ethyl ester; N-my- ristoyltyrosine; N-myristoyltyrosine-myristylester; N-palmi- toyltyrosine; N-palmitoyltyrosine-palmityl ester; N-stearo- yltyrosine and N-stearoyltyrosine stearyl ester.
- the preparation further comprises riboflavin.
- Riboflavin or vitamin B2 is 7 , 8-dimethyl-10 (D-l ' - ribityl) -isoalloxazine and is a compound which in the body is converted into two coenzymes, viz. FMN and FAD, which are involved in numerous oxidation-reduction processes.
- riboflavin as an activator in a sunburn preparation comprising a tyrosine derivative is known per se from CH 642 537.
- the use of riboflavin according to the invention is optional, moreover, rather than mandatory as in CH 642 537.
- this preparation further comprises a UV filter.
- the UV filter used can be any of the compounds suitable for this purpose in the customary quantities without any limitation.
- the tanning preparation according to the invention can further be in the form of a gel, lotion, cream, foam, spray based on water and/or an aqueous alcohol and/or an aqueous glycol, or of an emulsion of the type O/W, /O, 0/ /O, etc.
- Used as a solvent for aqueous solutions is, for example, water, aqueous ethanol, aqueous isopropanol, aqueous glycols or a mixture thereof.
- a suitable emulsifier it is possible to form an emulsion or a gel, while an aerosol or a foam can be formed with the aid of a suitable propellant.
- tyrosine derivatives carrying relatively long-chain substituents are preferably dissolved in an oil.
- mineral oils such as paraffin oil, vegetable oil such as olive oil and animal oil such as squalene.
- Waxes such as beeswax and fat-dissolving glycols and polyglycols can also be used, however.
- a tanning preparation according to the invention can comprise customary adjuvants, depending on the desired form of the preparation, such as surfactants, swelling agents or thickeners, emulsifiers and hydrolysed vegetable protein such as hydrolysed soya protein and hydrolysed wheat protein.
- the invention further relates to a method of preparing a tanning preparation as described hereinabove, which is characterized in that a mixture is formed which comprises 5 - 15 wt% of N-acetyl-L-tyrosine, 0.5 - 5 wt% of phytantriol, 15 - 25 wt% of butylene glycol,
- a mixture is formed which comprises 10 wt% of N-acetyl-L-tyrosine, 20 wt% of butylene glycol,
- the present invention relates to a controlled release tanning preparation.
- a controlled release tanning preparation With respect to the phenomenon of controlled release preparations the following explanation is given.
- Stable emulsions produced for application in food, pharmacy, personal care and cosmetics, lacquers and coatings, paper products, etc., are characterized by the presence of a nematic, liquid crystalline structure.
- thermodynamically stable liquid crystalline (LC) structures is dependant on the temperature, and it is a boundary condition for stable emulsions that these LC structures are manifest in the temperature range of storage and application of the particular product.
- the nematic liquid crystalline structures reside in the continuous phase of emulsions. These are organised in double layers whereby the theme "like-dissolves-like" is applicable.
- the double layers, relative to the continuous phase applicable, may be organised as:
- « H » represents the hydrophilic (water-loving) part of the surface active agent
- « L » represents the lipophilic (oil-loving) part of the surface active agent.
- structure (1) will reside in the water phase and is characteristic for Oil-in-Water (O/W) emulsions.
- Structure (2) will reside in the oil phase and is therefore characteristic for Water-in-Oil (W/O) emulsions .
- the LC structure is present in the form of a sponge structure. A number of parameters are determining the characteristics of the frequently called “the fourth phase” . These are:
- the mechanical strength of the LC is an important parameter for the cosmetic application of active ingredients relative to the bio-availability of these active ingredients.
- the LC structures are quickly deteriorated because of the influence of shear applied during rubbing in, the influence of electrolytes, the activity of enzymes present on the skin and because of the presence of liquid crystalline structures relative to the naturally occurring sebum (the sebum also exhibits liquid crystalline properties, and easily dissolves the LC structures present in cosmetic emulsions) .
- Active principles could be considered to be moisturisers/humectants, oil/water-soluble UV-filters, flavonoids, saponines, alkaloids, terpenoids, vitamins, 2- hydroxy carboxylic acids (AHA's), insect repellents, amino acid biovectors, (poly) -saccharides, etc.
- hydrocolloids such as naturals gums (such as xanthan gum, karaya gum, guar gum, gum ghatti, gum Arabic, etc.), cellulose derivatives (such as methylcellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methylcellulose, etc.), synthetic hydrophilic products such as homo-and co-polymers of acrylic acid, methacrylic acid, crotonic acid, etc, natural clays such as hectorites, bentonites, montmorrilonites, and others.
- naturals gums such as xanthan gum, karaya gum, guar gum, gum ghatti, gum Arabic, etc.
- cellulose derivatives such as methylcellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methylcellulose, etc.
- synthetic hydrophilic products such as homo-and co-polymers of acrylic acid, methacrylic acid, crotonic acid, etc, natural clay
- the mechanical strength of the LC structures can easily be measured in terms of rheological parameters such as yield stress value, visco-elastic behaviour and flow patterns.
- the same mechanism can be used for a controlled release mechanism of active substances.
- cholesterol can be pulled out of the double layer and make the contents of the liquid crystalline cavity available to the skin. This mechanism may coincide with enzymatic degradation of the liquid crystalline sponge structure. The naturally occuring receptors for cholesterol are thus used to enable controlled release.
- the mechanical strength can be increased by using the before mentioned hydrocolloids.
- Cholesterol is soluble in the liquid crystalline phase made of a variety of amphiphilic molecules and therefore an artificial membrane is formed that has similar properties as the naturally occurring subcutaneous membranes, and that is treated accordingly.
- the emollients can be chosen from the emollients, which are used in personal care and cosmetic preparations, in a concentration in the range 0-45 %, preferably in the range 5- 20%.
- Examples of applicable emollients are triglycerides of long chain, predominantly unsaturated fatty acids such as vegetable oils and artificially made triglycerides of long chain unsaturated fatty acids, triglycerides of saturated medium chain fatty acids, liquid and semi-solid esters of mono- & polyhydric alcohols and carboxylic acids with 1-24 carbon atoms, liquid and semi-solid fatty alcohols & branched alcohols, their ethoxylates and propoxylates , liquid and semi-solid mineral and natural hydrocarbons, products having a steroid skeleton with an hydroxy functionality, their esters, ethoxylates and propoxylates, water-soluble products made by ethoxylation and/or propoxylation of suitable mono- and/or polyhydric alcohols and products usually identified as silicones such as cyclic and linear polydimethylsiloxanes and polyphenyltrimethylsiloxanes and derivates thereof made by ethoxylation and/or propoxylation.
- An O/W lotion was prepared by mixing an oil phase and a water phase in a manner customary per se .
- the oil phase used consisted of: 0.50 kg of phenoxyethanol (Phenonip, trade name, product of Nipa Industries, UK) , 10.00 kg of an ester mixture, consisting of cetyl palmitate, octyl stearate and glyceryl stearate (Cetiol 868, product from Cognis) , 6.00 kg of emulsifier mixture of ceteareth-20 and ceteareth-12 (Emulgade SE, product from Cognis) , 2.00 kg of cetearyl alcohol (Lanette 0, product from Cognis) .
- the water phase consisted of 76.50 kg of water and 5.00 kg of tanning mixture according to the invention, consisting of:
- a gel-type preparation was prepared by mixing a premix consisting of:
- An 0/W lotion was formed in the same manner as in Example 1, and using the same substances and quantities, except that in the tanning mixture according to the invention the phytantriol used was replaced by adenosine triphosphate .
- a preparation of this type is disclosed by DE 37 32 154.
- the preparations specified in the abovementioned examples were subjected to tests on human skin, using a tanning bed comprising 22 80-Watt lamps and a face tanner comprising 5 15-Watt lamps.
- the measuring equipment consisted of a melanin & erythema meter (Mexameter MX16 from Courage &_ Khazaka) .
- the duration of an insolation was 20 minutes.
- Emulsions were made, composed as described in table 3.
- DMDM hydantoin 1, 3-bis- (hydroxymethyl) -5 , 5-dimethylimidazolidine- 2,4-dione.
- Isopropylisostearate is a spreading agent, which improves the spreadability of the preparation on the skin.
- Rheological additives are additives, which influence the mechanical strenght of the liquid crystalline structure of the emulsion to be prepared.
- the mixture is homogenised ⁇ 1500 rpm during 2 minutes, without stirring during the addition.
- the emulsion is stirred slowly with a planetary mixer while cooling gently.
- emulsion 1 The results of emulsion 1 were compared to a similar emulsion in absence of Cholesterol, Xanthan Gum and Acrylates/Cio-3o Alkyl Acrylates Crosspolymer, whereby the formed emulsion is stable but where the mechanical strength is greatly reduced: emulsion 2.
- Emulsion 2 has a much too high bio-availability of the moisturiser, while the system (emulsion 1) with build-in controlled release has a highly desirable bio-availability profile.
- Example 5
- Tanning acceleration using a controlled release tanning preparation according to the invention Tanning acceleration using a controlled release tanning preparation according to the invention.
- butyl methoxydibenzoylmethane is a strong sequestering agent for transition metal ions the use of an additional sequestering agent such as trisodium ETDA is essential to avoid coloration of the final emulsion.
- other UV filters can be used such as described in table 5 : the use of octocrylene instead of butyl methoxydibenzoylmethane & homosalate .
- the MEXAMETER readings were respectively 92% and 94 %.
- the bio-availability for the emulsion systems 5 A /5 B is such that less functional material can be used for the production of melanin.
- the lower MEXAMETER readings for emulsions 5 A /5 B is attributed to the absence of a controlled release system using cholesterol.
- the reduced bio-availability of the active ingredients (Acetyl Tyrosine/Pythantriol) probably originates from a high trans-epidermal flux of the active ingredients disabling full utilisation thereof.
- the activity of the system Acetyl Tyrosine / Phytantriol can thus be further improved using controlled release systems based on amphiphilic products that form a liquid crystalline (LC) phase in the emulsion.
- the mechanical strength of the LC phase can be monitored using a suitable rheological additive.
- Controlled release of active principles such as moisturisers or tanning accelerators can be monitored by incorporating cholesterol in the LC phase.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Colloid Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Plant Substances (AREA)
- Amplifiers (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Oscillators With Electromechanical Resonators (AREA)
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK01910238T DK1255531T3 (en) | 2000-02-15 | 2001-02-14 | Tanning preparation for skins |
AT01910238T ATE268589T1 (en) | 2000-02-15 | 2001-02-14 | SKIN TANNING PRODUCTS |
EP01910238A EP1255531B1 (en) | 2000-02-15 | 2001-02-14 | Tanning preparation for the skin |
AU2001237816A AU2001237816A1 (en) | 2000-02-15 | 2001-02-14 | Tanning preparation for the skin |
CA002400203A CA2400203A1 (en) | 2000-02-15 | 2001-02-14 | Tanning preparation for the skin |
DE60103735T DE60103735T2 (en) | 2000-02-15 | 2001-02-14 | HAUTBRAÜNUNGSMITTEL |
US10/218,037 US6649149B2 (en) | 2000-02-15 | 2002-08-14 | Tanning preparation for the skin |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL1014389A NL1014389C2 (en) | 2000-02-15 | 2000-02-15 | Tanning preparation for the skin. |
NL1014389 | 2000-02-15 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/218,037 Continuation US6649149B2 (en) | 2000-02-15 | 2002-08-14 | Tanning preparation for the skin |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001060330A1 true WO2001060330A1 (en) | 2001-08-23 |
Family
ID=19770822
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/NL2001/000122 WO2001060330A1 (en) | 2000-02-15 | 2001-02-14 | Tanning preparation for the skin |
Country Status (12)
Country | Link |
---|---|
US (1) | US6649149B2 (en) |
EP (2) | EP1255531B1 (en) |
AT (1) | ATE268589T1 (en) |
AU (1) | AU2001237816A1 (en) |
CA (1) | CA2400203A1 (en) |
DE (1) | DE60103735T2 (en) |
DK (1) | DK1255531T3 (en) |
ES (1) | ES2222982T3 (en) |
NL (1) | NL1014389C2 (en) |
PT (1) | PT1255531E (en) |
TR (1) | TR200402262T4 (en) |
WO (1) | WO2001060330A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002055029A2 (en) * | 2001-01-16 | 2002-07-18 | Roche Vitamins Ag | Hair protection compositions |
EP3124011A1 (en) * | 2015-07-28 | 2017-02-01 | Laboratoires M & L | Concentrated cosmetic formulation base |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US20120156144A1 (en) * | 2002-10-25 | 2012-06-21 | Foamix | Foamable Compositions, Kits and Methods for Hyperhidrosis |
US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
MXPA05004278A (en) | 2002-10-25 | 2005-10-05 | Foamix Ltd | Cosmetic and pharmaceutical foam. |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
BRPI0405956A (en) * | 2004-12-29 | 2006-09-05 | Natura Cosmeticos Sa | cosmetic composition and process for preparing said cosmetic composition and cosmetic product |
BRPI0503719A (en) | 2005-09-09 | 2007-09-25 | Natura Cosmeticos Sa | cosmetic composition and process of preparing said composition |
US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
KR20090044269A (en) * | 2007-10-31 | 2009-05-07 | (주)아모레퍼시픽 | Sustained-release nanoparticle and the cosmetic composition containing the same |
WO2009069006A2 (en) | 2007-11-30 | 2009-06-04 | Foamix Ltd. | Foam containing benzoyl peroxide |
WO2009072007A2 (en) | 2007-12-07 | 2009-06-11 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
US20120087872A1 (en) | 2009-04-28 | 2012-04-12 | Foamix Ltd. | Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof |
WO2011013008A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
WO2011013009A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
MX359879B (en) | 2009-10-02 | 2018-10-12 | Foamix Pharmaceuticals Ltd | Topical tetracycline compositions. |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
WO2011100358A2 (en) * | 2010-02-09 | 2011-08-18 | Fabrico Technology, Inc. | Systems and methods for detecting target analytes |
US9301521B2 (en) * | 2013-03-13 | 2016-04-05 | The United States Of America, As Represented By The Secretary Of Agriculture | Bee attractants |
US10398641B2 (en) | 2016-09-08 | 2019-09-03 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
KR102598477B1 (en) | 2016-09-21 | 2023-11-06 | (주)아모레퍼시픽 | Oil-in-water cosmetic composition |
EP3498256A1 (en) * | 2017-12-12 | 2019-06-19 | Spray Company SRL | Cosmetic formulation for the removal of skin stains |
DE102018107718A1 (en) * | 2018-03-29 | 2019-10-02 | Ultrasun Ag | A process for the preparation of a starting formulation for a dermatological sunscreen composition and for the preparation of a dermatological sunscreen composition |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3836849A1 (en) * | 1987-12-09 | 1989-06-22 | Induchem Ag | PRAEPARAT, COSMETIC SUN PROTECTION AGAIN, AND METHOD OF INTRODUCING AN ACTIVE INGREDIENT IN THE SKIN |
US5372805A (en) * | 1992-07-16 | 1994-12-13 | Bayer Aktiengesellschaft | Cosmetic sunscreen |
GB2304573A (en) * | 1995-08-31 | 1997-03-26 | Fernsoft | Skin care composition comprising sunscreen, humectant and exfolliant |
US5756108A (en) * | 1994-11-10 | 1998-05-26 | L'oreal | Oily phase in an aqueous phase dispersion stabilized by cubic gel particles and method of making |
US5834013A (en) * | 1994-06-08 | 1998-11-10 | L'oreal | Cosmetic or dermatological composition in the form of an aqueous and stable dispersion of cubic gel particles based on phytanetriol and containing a surface-active agent which has a fatty chain, as dispersing and stabilizing agent |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69103487T2 (en) * | 1990-07-11 | 1995-02-16 | Quest Int | Perfumed structured emulsions in personal care products. |
GB9420535D0 (en) * | 1994-10-12 | 1994-11-30 | Procter & Gamble | Cosmetic make-up compositions |
US5656280A (en) * | 1994-12-06 | 1997-08-12 | Helene Curtis, Inc. | Water-in-oil-in-water compositions |
US5744062A (en) * | 1996-08-29 | 1998-04-28 | R.I.T.A. Corporation | Balanced emulsifier blends for oil-in-water emulsions |
DE19645319A1 (en) * | 1996-11-04 | 1998-05-07 | Beiersdorf Ag | Foaming composition, useful as skin care medium e.g. as shaving foam |
SK283697B6 (en) * | 1999-03-03 | 2003-12-02 | Slovakofarma, A. S. | Dermatological compositions containing a liquid crystal vehicle and method of preparing same |
-
2000
- 2000-02-15 NL NL1014389A patent/NL1014389C2/en not_active IP Right Cessation
-
2001
- 2001-02-14 PT PT01910238T patent/PT1255531E/en unknown
- 2001-02-14 CA CA002400203A patent/CA2400203A1/en not_active Abandoned
- 2001-02-14 EP EP01910238A patent/EP1255531B1/en not_active Expired - Lifetime
- 2001-02-14 TR TR2004/02262T patent/TR200402262T4/en unknown
- 2001-02-14 AU AU2001237816A patent/AU2001237816A1/en not_active Abandoned
- 2001-02-14 DK DK01910238T patent/DK1255531T3/en active
- 2001-02-14 AT AT01910238T patent/ATE268589T1/en not_active IP Right Cessation
- 2001-02-14 DE DE60103735T patent/DE60103735T2/en not_active Expired - Lifetime
- 2001-02-14 WO PCT/NL2001/000122 patent/WO2001060330A1/en active IP Right Grant
- 2001-02-14 ES ES01910238T patent/ES2222982T3/en not_active Expired - Lifetime
- 2001-02-14 EP EP04076607A patent/EP1468668A3/en not_active Withdrawn
-
2002
- 2002-08-14 US US10/218,037 patent/US6649149B2/en not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3836849A1 (en) * | 1987-12-09 | 1989-06-22 | Induchem Ag | PRAEPARAT, COSMETIC SUN PROTECTION AGAIN, AND METHOD OF INTRODUCING AN ACTIVE INGREDIENT IN THE SKIN |
US5372805A (en) * | 1992-07-16 | 1994-12-13 | Bayer Aktiengesellschaft | Cosmetic sunscreen |
US5834013A (en) * | 1994-06-08 | 1998-11-10 | L'oreal | Cosmetic or dermatological composition in the form of an aqueous and stable dispersion of cubic gel particles based on phytanetriol and containing a surface-active agent which has a fatty chain, as dispersing and stabilizing agent |
US5756108A (en) * | 1994-11-10 | 1998-05-26 | L'oreal | Oily phase in an aqueous phase dispersion stabilized by cubic gel particles and method of making |
GB2304573A (en) * | 1995-08-31 | 1997-03-26 | Fernsoft | Skin care composition comprising sunscreen, humectant and exfolliant |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002055029A2 (en) * | 2001-01-16 | 2002-07-18 | Roche Vitamins Ag | Hair protection compositions |
WO2002055029A3 (en) * | 2001-01-16 | 2002-12-12 | Roche Vitamins Ag | Hair protection compositions |
EP3124011A1 (en) * | 2015-07-28 | 2017-02-01 | Laboratoires M & L | Concentrated cosmetic formulation base |
FR3039396A1 (en) * | 2015-07-28 | 2017-02-03 | Laboratoires M&L | BASE OF CONCENTRATED COSMETIC FORMULATION |
Also Published As
Publication number | Publication date |
---|---|
US20030118527A1 (en) | 2003-06-26 |
AU2001237816A1 (en) | 2001-08-27 |
DE60103735T2 (en) | 2005-06-23 |
DE60103735D1 (en) | 2004-07-15 |
DK1255531T3 (en) | 2004-10-18 |
PT1255531E (en) | 2004-10-29 |
EP1255531B1 (en) | 2004-06-09 |
TR200402262T4 (en) | 2004-12-21 |
CA2400203A1 (en) | 2001-08-23 |
US6649149B2 (en) | 2003-11-18 |
EP1255531A1 (en) | 2002-11-13 |
EP1468668A2 (en) | 2004-10-20 |
NL1014389C2 (en) | 2001-08-16 |
EP1468668A3 (en) | 2005-02-02 |
ATE268589T1 (en) | 2004-06-15 |
ES2222982T3 (en) | 2005-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1255531B1 (en) | Tanning preparation for the skin | |
EP0934053B1 (en) | Cosmetic or dermatological microemulsions | |
JP3687277B2 (en) | Whitening cosmetics | |
JP3595206B2 (en) | Cosmetic and / or dermatological compositions containing salicylic acid or salicylic acid derivatives and uses thereof | |
EP1513492B1 (en) | Microemulsions having a binary phase differentiability and active substance differentiability, the production thereof and their use, particularly for the topical supply of oxygen | |
JP3162342B2 (en) | Use of arbutin monoester as depigmenting agent | |
EP0754449A1 (en) | Skin whitening composition and/or anti-aging composition and uses thereof | |
EP0646368B1 (en) | A gel-resembling composition containing organopolysiloxane, without a gelling agent used in cosmetic and dermatology | |
US9827194B2 (en) | Surfactant-free oil-in-water type emulsion, process for preparation thereof and its uses | |
US20090130036A1 (en) | Self tanning product having slimming, firming and toning properties associated therewith | |
MX2012013506A (en) | Polymer combinations for cosmetic preparations. | |
EP1282393B1 (en) | External application for enhancing the skin permeability of the active components therein | |
EP2100586A1 (en) | Cosmetic composition comprising an ascorbic acid or salicylic acid compound | |
JP2002138014A (en) | Fine emulsion composition | |
CA2181738A1 (en) | Cosmetic or dermatological filtering composition | |
EP0679388B1 (en) | Cosmetic and/or dermatologic skin depigmentation composition and its use | |
DE10057767A1 (en) | Deodorant and antiperspirant composition comprises dispersed liquid crystals forming a cubic phase | |
US20010053350A1 (en) | Cosmetic composition comprising N-ethyloxycarbonyl-4-amino-phenol and arbutin or its derivatives and/or ellagic acid or its derivatives | |
JP3643690B2 (en) | Skin preparation | |
JP3382146B2 (en) | External preparation for skin | |
JP2001240511A (en) | Composition comprising n-cholesteryloxycarbonyl-4- paraaminophenol and one of hydroquinone or its derivative as base | |
JP2000198724A (en) | Skin-beautifying preparation for external use for skin | |
JP3400313B2 (en) | Percutaneous absorption promoting skin external preparation | |
MXPA99007373A (en) | Cosmetic and/or dermatological composition containing salicylic acid or its derivatives and its use | |
JP2004026698A (en) | Humectant and skin care preparation for external use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2001910238 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2400203 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10218037 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2001910238 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 2001910238 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |